Search Results - "Dentener, MA"

Refine Results
  1. 1

    Enhanced levels of hyaluronan in lungs of patients with COPD: relationship with lung function and local inflammation by Dentener, M A, Vernooy, J H J, Hendriks, S, Wouters, E F M

    Published in Thorax (01-02-2005)
    “…Background: Chronic inflammation and airway remodelling are characteristics of chronic obstructive pulmonary disease (COPD). Hyaluronan (HA) is an…”
    Get full text
    Journal Article
  2. 2

    Long-Term Intratracheal Lipopolysaccharide Exposure in Mice Results in Chronic Lung Inflammation and Persistent Pathology by Vernooy, Juanita H. J, Dentener, Mieke A, van Suylen, Robert J, Buurman, Wim A, Wouters, Emiel F. M

    “…Lipopolysaccharide (LPS), a major proinflammatory glycolipid component of the gram-negative bacterial cell wall, is one of the agents ubiquitously present as…”
    Get full text
    Journal Article
  3. 3

    Childhood asthma: Exhaled markers of airway inflammation, asthma control score, and lung function tests by Rosias, Philippe P.R., Dompeling, Edward, Dentener, Mieke A., Pennings, Herman J., Hendriks, Han J.E., Van Iersel, Monique P.A., Jöbsis, Quirijn

    Published in Pediatric pulmonology (01-08-2004)
    “…Exhaled markers of airway inflammation become increasingly important in the management of childhood asthma. The aims of the present study are: 1) to compare…”
    Get full text
    Journal Article
  4. 4

    Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease by Schols, A. M., Buurman, W. A., Staal van den Brekel, A. J., Dentener, M. A., Wouters, E. F.

    Published in Thorax (01-08-1996)
    “…BACKGROUND: An increase in resting energy expenditure (REE) commonly occurs in patients with chronic obstructive pulmonary disease (COPD), the cause of which…”
    Get full text
    Journal Article
  5. 5

    Systemic anti-inflammatory mediators in COPD: increase in soluble interleukin 1 receptor II during treatment of exacerbations by Dentener, M A, Creutzberg, E C, Schols, A M W J, Mantovani, A, van‘t Veer, C, Buurman, W A, Wouters, E F M

    Published in Thorax (01-09-2001)
    “…BACKGROUND The aim of this study was to test the hypothesis that the chronic inflammatory process present in chronic obstructive pulmonary disease (COPD) is…”
    Get full text
    Journal Article
  6. 6

    Disturbances in leptin metabolism are related to energy imbalance during acute exacerbations of chronic obstructive pulmonary disease by CREUTZBERG, E. V. A. C, WOUTERS, Emiel F. M, VANDERHOVEN-AUGUSTIN, Ingrid M. L, DENTENER, Mieke A, SCHOLS, Annemie M. W. J

    “…Previously we reported an impaired energy balance in patients with chronic obstructive pulmonary disease (COPD) during an acute disease exacerbation, but…”
    Get full text
    Journal Article
  7. 7

    Intratracheal instillation of lipopolysaccharide in mice induces apoptosis in bronchial epithelial cells: no role for tumor necrosis factor-alpha and infiltrating neutrophils by Vernooy, J H, Dentener, M A, van Suylen, R J, Buurman, W A, Wouters, E F

    “…This study investigated apoptosis in lungs after local exposure to lipopolysaccharide (LPS). Mice were instilled intratracheally with 5 microg LPS, which…”
    Get full text
    Journal Article
  8. 8

    Differences in local versus systemic TNFα production in COPD: inhibitory effect of hyaluronan on LPS induced blood cell TNFα release by Dentener, M A, Louis, R, Cloots, R H E, Henket, M, Wouters, E F M

    Published in Thorax (01-06-2006)
    “…Background: Chronic obstructive pulmonary disease (COPD) is characterised by both airway inflammation and systemic changes. To elucidate the relationship…”
    Get full text
    Journal Article Web Resource
  9. 9
  10. 10

    Leptin as local inflammatory marker in COPD by Broekhuizen, R., Vernooy, J.H.J., Schols, A.M.W.J., Dentener, M.A., Wouters, E.F.M.

    Published in Respiratory medicine (2005)
    “…Introduction: Chronic inflammation of the lung is a characteristic finding in chronic obstructive pulmonary disease (COPD). Leptin is a pleiotropic cytokine…”
    Get full text
    Journal Article
  11. 11

    Lipopolysaccharide Binding Protein and Serum Amyloid A Secretion by Human Intestinal Epithelial Cells During the Acute Phase Response by Vreugdenhil, Anita C. E, Dentener, Mieke A, Snoek, A. M. Patricia, Greve, Jan-Willem M, Buurman, Wim A

    Published in The Journal of immunology (1950) (01-09-1999)
    “…The acute phase proteins LPS binding protein (LBP) and serum amyloid A (SAA) are produced by the liver and are present in the circulation. Both proteins have…”
    Get full text
    Journal Article
  12. 12

    Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism by van der Pouw Kraan, T C T M, Küçükaycan, M, Bakker, A M, Baggen, J M C, van der Zee, J S, Dentener, M A, Wouters, E F M, Verweij, C L

    Published in Genes and immunity (01-11-2002)
    “…IL-13 is strongly implicated in the development of asthma and chronic obstructive pulmonary disease (COPD). We previously identified an IL-13 promoter…”
    Get full text
    Journal Article
  13. 13

    Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor- alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages by Dentener, MA, Bazil, V, Von Asmuth, EJ, Ceska, M, Buurman, WA

    Published in The Journal of immunology (1950) (01-04-1993)
    “…CD14 has been reported to function as a receptor for bacterial LPS complexed with serum proteins, transducing an activation signal for TNF-alpha production. We…”
    Get full text
    Journal Article
  14. 14

    Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors by Bouma, MG, Jeunhomme, TM, Boyle, DL, Dentener, MA, Voitenok, NN, van den Wildenberg, FA, Buurman, WA

    Published in The Journal of immunology (1950) (01-06-1997)
    “…Adenosine, acting via A2 receptors, is a potent inhibitor of neutrophil oxidative burst, but its effects and mechanisms of action on neutrophil degranulation…”
    Get full text
    Journal Article
  15. 15

    Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients by Staal-van den Brekel, A J, Dentener, M A, Schols, A M, Buurman, W A, Wouters, E F

    Published in Journal of clinical oncology (01-10-1995)
    “…To determine whether an increased resting energy expenditure (REE) and weight loss in lung cancer patients are related to a systemic inflammatory response. REE…”
    Get more information
    Journal Article
  16. 16

    Lipopolysaccharide-binding protein is produced in the epididymis and associated with spermatozoa and prostasomes by Malm, Johan, Nordahl, Emma Andersson, Bjartell, Anders, Sørensen, Ole E., Frohm, Birgitta, Dentener, Mieke A., Egesten, Arne

    Published in Journal of reproductive immunology (01-06-2005)
    “…Lipopolysaccharide-binding protein (LBP) is an acute phase protein known to play a central role in the defense against Gram-negative bacteria. It binds…”
    Get full text
    Journal Article
  17. 17

    The Bactericidal/Permeability-Increasing Protein (BPI) Is Present in Specific Granules of Human Eosinophils by Calafat, Jero, Janssen, Hans, Tool, Anton, Dentener, Mieke A., Knol, Edward F., Rosenberg, Helene F., Egesten, Arne

    Published in Blood (15-06-1998)
    “…Eosinophils participate in the inflammatory response seen in allergy and parasitic infestation, but a role in host defense against bacterial infection is not…”
    Get full text
    Journal Article
  18. 18

    Strong Association of Interleukin-6 and Lipopolysaccharide-Binding Protein with Severity of Adverse Reactions after Diethylcarbamazine Treatment of Microfilaremic Patients by Haarbrink, M., Abadi, G. K., Buurman, W. A., Dentener, M. A., Terhell, A. J., Yazdanbakhsh, M.

    Published in The Journal of infectious diseases (01-08-2000)
    “…To assess the involvement of inflammatory mediators in the development of adverse reactions in filarial patients undergoing treatment, 29 microfilaremic…”
    Get full text
    Journal Article
  19. 19

    Lipopolysaccharide LPS-mediated soluble TNF receptor release and TNF receptor expression by monocytes. Role of CD14, LPS binding protein, and bactericidal/permeability-increasing protein by Leeuwenberg, JF, Dentener, MA, Buurman, WA

    Published in The Journal of immunology (1950) (15-05-1994)
    “…Previously we demonstrated that two soluble(s) tumor necrosis factor receptors, TNF-R55 as well as sTNF-R75, are constitutively released in vitro by monocytes,…”
    Get full text
    Journal Article
  20. 20

    Lipopolysaccharide Toxicity-Regulating Proteins in Bacteremia by Froon, Albert H. M., Dentener, Mieke A., Greve, Jan Willem M., Ramsay, Graham, Buurman, Wim A.

    Published in The Journal of infectious diseases (01-05-1995)
    “…The toxicity of lipopolysaccharide (LPS) is modified by several proteins, such as bactericidal/permeability-increasing protein (BPI) and LPS-binding protein…”
    Get full text
    Journal Article